Program at a Glance​

  • Session times are Korea Standard Time (UTC/GMT+9). Please click the Time Zone Converter button and check your local time.
  • The program is subject to change.
  • If you click the session code, it will lead you to details of the Scientific Programs.
  • We will notify you later about the details of the poster/oral presentation.

SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [SP] Special Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [LS] Luncheon Symposium, [SL] Satellite Symposium, [OP] Oral Presentation, [PD] Poster Discussion

Sep.2 (WED) Date Sep.3 (THU)
Room D Time Room A Room B Room C Room D Room E
08:30-10:00 JS01
ASCO/KSMO
JS02
KCSG/KSMO
(08:30-09:50)​



SS01 ES01 SL01
(8:30-9:10)
 
SL02
(9:20-10:00)
Break (20 min.)
10:00-10:10 Break (10 min.) Break (10 min.)
10:10-10:30 Opening Ceremony
10:30-11:10 PL01
11:10-11:20 Break (10 min.)
11:20-12:00 LS01
LS02
LS03
LS04
LS05
12:00-12:10 Break (10 min.)
12:10-13:40 SS02
(12:10-13:30)​
JS03
KOSRO/KSMO
SS03
(12:10-13:30)​
ES02 SL03
(12:10-12:50)
SP01
(12:20-13:50)
SL04
(13:00-13:40)
Break (20 min.) Break (20 min.)
13:40-13:50 Break (10 min.) Break (10 min.)
Break (15 min.)

13:50-15:20 JS04
ESMO/KSMO
OP01
(13:50-14:50)

SS04
(13:50-15:10)​
ES03
(13:50-15:10)​
SL05
(13:50-14:30)
SP02
(14:05-16:05)

SL06
(14:30-15:10)
PD01
(14:50-15:20)

Break (20 min.)
15:20-15:30 Break (10 min.)
15:30-16:10 PL02
(15:30-16:10)
Break (15 min.)

16:10-17:40 SS05 JS05
KSSO/KSMO
SS06 JS06
KSR/KSMO
SL07
(16:10-16:50)
SP03
(16:20-17:50)
SL08
(17:00-17:40)
17:40-17:50
Break (10 min.) 17:50-18:00
Welcome Reception
(18:00-)
18:00~
Date Sep.4 (FRI)
Time Room A Room B Room C Room D Room E
08:30-10:00 JS07
JSMO/KSMO
JS08
KSP/KSMO
MDCD
(08:30-09:50)​




ES04 SL09
(8:30-9:10)
 
SL10
(9:20-10:00)
Break (30 min.)
10:00-10:20 Break (20 min.)

Break (20 min.)
10:20-11:00 PL03
(10:20-11:00)
11:00-11:20 Break (20 min.)

11:20-12:00 LS06
LS07
LS08
LS09
LS10
12:00-12:10 Break (10 min.)
12:10-13:40 JS09
ASCO/KSMO
SS07






SS08 FACO 1
(12:10-13:30)​
SL11
(12:10-12:50)
SL12
(12:50-13:30)
Break (20 min.)
13:40-13:50 Break (10 min.)
13:50-14:30 PL04
(13:50-14:30)
 
14:30-14:40 Break (10 min.)
14:40-16:10 JS10
ESMO/KSMO
OP02
(14:40-15:40)
SS09
(14:40-16:00)​


FACO 2
(14:40-16:00)​
SL13
(14:40-15:20)
SL14
(15:30-16:10)

PD02
(15:40-16:10)
Break (10 min.)
16:10-16:30 Closing Ceremony
(16:10-16:30)
 
Date Sep.2 (WED)
Time Room D
12:20-13:50 SP01

Past, present and future of precision oncology clinical trials: Legacy of KOSMOS trial
13:50-14:05 Break (15 min.)
14:05-16:05 SP02
16:05-16:20 Break (15 min.)
16:20-17:50 SP03

Artificial intelligence in medical oncology: Learning from clinics, images, and tissue
17:50-18:00 Break (10 min.)
18:00~ Welcome Reception
Date Sep.3 (THU)
Time Room A Room B Room C Room D Room E
08:30-10:00 JS01
ASCO/KSMO

How neoadjuvant therapy is redefining the surgeon-oncologist partnership
JS02
KCSG/KSMO
(08:30-09:50)​

Maximizing cure in early stage-cancer
SS01

Scientific breakthroughs in palliative oncology: Evidence-based symptom science
ES01

Real-world geriatric oncology: Transition from research to practice

KOR

SL01
(8:30-9:10)
 
SL02
(9:20-10:00)
Break (20 min.)
10:00-10:10 Break (10 min.) Break (10 min.)
10:10-10:30 Opening Ceremony
10:30-11:10 PL01

New concepts in cancer biology: From the microbiome to non-coding DNA
11:10-11:20 Break (10 min.)
11:20-12:00 LS01
LS02
LS03
LS04
LS05
12:00-12:10 Break (10 min.)
12:10-13:40 SS02
(12:10-13:30)

Integrating advanced systemic therapies for localizd gastrointestinal cancers: Transforming palliation into cure
JS03
KOSRO/KSMO

Refining management of central nervous system tumors
SS03
(12:10-13:30)

Tissue-agnostic oncology in rare cancers : When biology outgrows histology
ES02

ctDNA in the clinic: Evidence, interpretation, and real-world decisions

KOR

SL03
(12:10-12:50)
SL04
(13:00-13:40)
Break (20 min.) Break (20 min.)
13:40-13:50 Break (10 min.) Break (10 min.)
13:50-15:20 JS04
ESMO/KSMO

Implementation of AI in cancer care
OP01
(13:50-14:50)
SS04
(13:50-15:10)

Evolving standards of care in GU malignancies
ES03
(13:50-15:10)
From bench to clinic: Recent advance of ADC and BiTE in precision oncology

KOR

SL05
(13:50-14:30)
SL06
(14:30-15:10)
PD01
(14:50-15:20)
Break (20 min.)
15:20-15:30 Break (10 min.)
15:30-16:10 PL02

RAS: What have we learned, what are we learning, what do we need to learn!
16:10-17:40 SS05

Biomarker-driven precision oncology in breast cancer
JS05
KSSO/KSMO

Clinical applications of ctDNA for minimal residual disease across solid tumors
SS06

Novel opportunities to target cancer: Emerging strategies in molecular oncology
JS06
KSR/KSMO

Quantitative imaging biomarkers for precision oncology
SL07
(16:10-16:50)
SL08
(17:00-17:40)
17:40-17:50
Date Sep.4 (FRI)
Time Room A Room B Room C Room D Room E
08:30-10:00 JS07
JSMO/KSMO

From evidence to practice; The rise of chemo-IO combination in the perioperative setting
JS08
KSP/KSMO

Integrating digital pathology and spatial biology: Emerging insights for precision oncology
MDCD
(08:30-09:50)

Integrated multidisciplinary strategies in lung cancer care: Lessons from real-world cases

KOR

ES04

Experimental technology for precision medicine

KOR

SL09
(8:30-9:10)
 
SL10
(9:20-10:00)
Break (30 min.)
10:00-10:20 Break (20 min.) Break (20 min.)
10:20-11:00 PL03

ctDNA and minimal residual disease in colorectal cancer: Evidence, challenges and the road ahead (Tentative)
 
11:00-11:20 Break (20 min.)
11:20-12:00 LS06
LS07
LS08
LS09
LS10
12:00-12:10 Break (10 min.)
12:10-13:40 JS09
ASCO/KSMO

From data to decisions: AI and real-world evidence transforming oncology practice
SS07

Evolving targeted therapies for gastrointestinal cancers: Navigating new frontiers beyond established standards
SS08

The evolving landscape of cell-based and engager therapies for solid cancers
FACO 1 SL11
(12:10-12:50)
SL12
(12:50-13:30)
Break (20 min.)
13:40-13:50 Break (10 min.)
13:50-14:30 PL04

Encouraging results and updates on personalized cancer vaccines
 
14:30-14:40 Break (10 min.)
14:40-16:10 JS10
ESMO/KSMO

ESMO guidelines on the management of breast cancer
OP02
(14:40-15:40)
SS09
(14:40-16:00)

State of the art therapy and future direction of EGFR-Mutant NSCLC
FACO 2
(14:40-16:00)​
SL13
(14:40-15:20)
SL14
(15:30-16:10)
PD02
(15:40-16:10)
Break (10 min.)
16:10-16:30 Closing Ceremony
(16:10-16:30)